Zenas BioPharma, Inc. Debt Securities, Available-for-sale, Current
Zenas BioPharma, Inc. (ZBIO) had Debt Securities, Available-for-sale, Current of $477.31 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale, Current $477.31M.
- 2026-03-31: Debt Securities, Available-for-sale, Current $218.32M.
- 2025-12-31: Debt Securities, Available-for-sale, Current $249.82M.
- 2025-09-30: Debt Securities, Available-for-sale, Current $186.04M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2026-06-30 | $477.31M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $218.32M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $249.82M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $186.04M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $230.89M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $117.66M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $31.02M 10-K · filed 2026-03-16 |
| 2024-09-30 | $26.76M 10-Q · filed 2024-11-12 |